United Health Products, Inc. Overview
Pro stress-test →United Health Products is a developer, manufacturer and marketer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds and help control bleeding, serving hospitals, surgery centers, clinics, physicians, military medical care providers, hemodialysis centers, nursing homes, and veterinary hospitals.
Strategic Profile
Pro stress-test →The company's main product is a bio-compatible sterile gauze that produces hemostasis, or stops bleeding, when applied to a cut or open wound. The company has been pursuing FDA Premarket Approval (PMA) for its flagship HemoStyp product, with regulatory progress documented through 2024, though final approval status remains pending as of mid-2026.
Competitive Landscape
Pro stress-test →The hemostatic gauze market includes established players in absorbent wound care and bleeding control. Primary competitors include Baxter International (advanced hemostatic solutions), DENTSPLY SIRONA (dental/surgical products), and specialty wound care manufacturers like Sanuwave Health. UHP's differentiator is its proprietary NORC technology and multi-market distribution strategy, though it operates at significantly smaller scale than established competitors.
Industry Context
United Health Products, Inc. operates in Hemostatic wound care devices.
Key facts
Founded: 1997 · Headquarters: Mount Laurel, New Jersey · Employees: N/A · Revenue: N/A · Market cap: N/A